[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Morton, 2007 - Google Patents

Hypothalamic leptin regulation of energy homeostasis and glucose metabolism

Morton, 2007

View PDF
Document ID
3356437608345160629
Author
Morton G
Publication year
Publication venue
The Journal of physiology

External Links

Snippet

Growing evidence suggests that food intake, energy expenditure and endogenous glucose production are regulated by hypothalamic areas that respond to a variety of peripheral signals. Therefore, in response to a reduction in energy stores or circulating nutrients, the …
Continue reading at physoc.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Similar Documents

Publication Publication Date Title
Morton Hypothalamic leptin regulation of energy homeostasis and glucose metabolism
Yavari et al. Chronic activation of γ2 AMPK induces obesity and reduces β cell function
Harvey Leptin: a diverse regulator of neuronal function
Lam et al. CNS regulation of glucose homeostasis
Flak et al. Minireview: CNS mechanisms of leptin action
Morton et al. Leptin and the central nervous system control of glucose metabolism
Lin et al. Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues
Morton et al. Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons
Prodi et al. Minireview: the brain as a molecular target for diabetic therapy
Van der Klaauw et al. The hunger genes: pathways to obesity
López et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin
Porte Jr et al. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans
Knight et al. Hyperleptinemia is required for the development of leptin resistance
Denroche et al. The role of leptin in glucose homeostasis
Theander-Carrillo et al. Ghrelin action in the brain controls adipocyte metabolism
Dzamko et al. AMPK‐dependent hormonal regulation of whole‐body energy metabolism
Thon et al. Possible integrative actions of leptin and insulin signaling in the hypothalamus targeting energy homeostasis
Niswender et al. Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities
Ioffe et al. Abnormal regulation of the leptin gene in the pathogenesis of obesity
Gault et al. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets
Moro et al. Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity
Meek et al. Leptin, diabetes, and the brain
Schwartz et al. Adiposity signaling and biological defense against weight gain: absence of protection or central hormone resistance?
Scherer et al. Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism
Obici Molecular targets for obesity therapy in the brain